REPLIGEN CORP·4

Oct 3, 8:44 PM ET

Loeillot Olivier 4

4 · REPLIGEN CORP · Filed Oct 3, 2023

Insider Transaction Report

Form 4
Period: 2023-10-02
Loeillot Olivier
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-02+24,23624,236 total
    Exercise: $154.96Exp: 2033-10-02Common Stock (24,236 underlying)
  • Award

    Common Stock

    2023-10-02+12,90612,906 total
Footnotes (2)
  • [F1]Mr. Loeillot was awarded 12,906 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal installments over a five-year period with each such vesting date occurring on the anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
  • [F2]The shares vest in equal annual installments over a five-year period with each such vesting date occurring on the anniversary of the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4